Merck Tbk PT

Merck Tbk PT Current Assets

The Current Assets of Merck Tbk PT (MERK.JK) as of Oct 22, 2026 is 781.73 B IDR. In the previous year, Current Assets was 751.74 B IDR — a change of 3.99% (higher).

Current Assets

781.73 BIDR

YoY

3.99%

Last updated:

Current Assets of Merck Tbk PT is 2025 781.73 B IDR. Current Assets of Merck Tbk PT was 2024 751.74 B IDR. It decreases by 3.99% higher compared to the previous year.

The Merck Tbk PT Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
1.11 T IDR
Jan 1, 2019
675.01 B IDR
Jan 1, 2020
678.45 B IDR
Jan 1, 2021
768.16 B IDR
Jan 1, 2022
795.59 B IDR
Jan 1, 2023
718.19 B IDR
Jan 1, 2024
751.74 B IDR
Jan 1, 2025
781.73 B IDR
The Merck Tbk PT Current Assets history
YEARCurrent AssetsYoY
781.73 BIDR+3.99%
751.74 BIDR+4.67%
718.19 BIDR-9.73%
795.59 BIDR+3.57%
768.16 BIDR+13.22%
678.45 BIDR+0.51%
675.01 BIDR-39.24%
1.11 TIDR+93.72%
573.48 BIDR+11.82%
512.86 BIDR+3.87%
493.74 BIDR-17.24%
596.57 BIDR+1.18%
589.59 BIDR+27.10%
463.88 BIDR-5.66%
491.73 BIDR+51.25%
325.12 BIDR-4.37%
339.99 BIDR+13.83%
298.67 BIDR+13.34%
263.51 BIDR+20.31%
219.02 BIDR+43.59%
152.53 BIDR+34.35%
113.53 BIDR+11.03%
102.25 BIDR+15.18%
88.77 BIDR-6.60%
95.05 BIDR+29.00%
73.68 BIDR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Merck Tbk PT Stock analysis

What does Merck Tbk PT do? Merck Tbk PT generates revenue through its Biopharma segment, which focuses on ethical pharmaceutical products for serious diseases. The company also earns from Consumer Health, offering over-the-counter products that support personal wellness and family planning needs. Its 'Others' segment includes additional business activities. The firm serves healthcare providers, pharmacies, and individual consumers seeking personalized treatments and accessible health solutions. Biopharma targets medical professionals and hospitals with specialized treatments for critical conditions. Consumer Health products are sold directly to consumers through retail channels for daily health management. The company's business model relies on delivering tailored healthcare solutions across its three operational segments to meet diverse market demands. Merck Tbk PT's revenue streams are structured around pharmaceutical innovations and consumer health products. Ethical products in Biopharma address unmet medical needs, while over-the-counter offerings in Consumer Health cater to everyday health requirements. The firm's focus on personalized care ensures consistent demand from both professional and individual customers. Merck Tbk PT is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Merck Tbk PT stock

Current Assets of Merck Tbk PT is 781.73 B IDR in 2025.

Current Assets of Merck Tbk PT changed from 751.74 B IDR to 781.73 B IDR, representing a 3.99% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Merck Tbk PT since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's IDR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Merck Tbk PT historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Merck Tbk PT

All Key Metrics — Merck Tbk PT